MannKind’s shares tumble; deal unlikely in 2009
07-Oct-2009 - MannKind’s share price tumbled by 31 per cent yesterday, just days after it published encouraging...
News in brief
India’s formulation market worth $14bn by 2013, says Angel Broking
05-Oct-2009 - India’s drug formulation market will grow 12 per cent a year and be worth $13.7bn...
OctoPlus reduces workforce by 25% to boost efficiency
29-Sep-2009 - Dutch contract delivery services firm OctoPlus says it will cut 35 jobs as part of...
West opens its first manufacturing site in China
28-Sep-2009 - West has opened its first manufacturing facility in China to meet rising demand but the...
News in brief
EC OKs Novartis’ move for Ebewe SP's injectables biz
24-Sep-2009 - The European Commission has approved Novartis’ €925m ($1.2bn) acquisition of Ebewe Spezial-Pharma’s generic injectables business. ...
News in brief
Octoplus lands CF drug deal with Axentis
14-Sep-2009 - Octoplus has signed a new contract with develop and manufacture Axentis Pharma’s lead product, a...
Biologics boost for $2.7bn needle-free delivery market
14-Sep-2009 - Demand for new delivery options for biologic drugs will drive an expansion of the $2.7bn...
Targeted Genetics out of crisis after selling AAV kit to Genzyme
10-Sep-2009 - Struggling biotech Targeted Genetics (TG) has sold certain patents and AAV manufacturing technology to fellow...
Encap targets growth opportunities in colonic delivery
08-Sep-2009 - CMO Encap has expanded its colonic delivery offering and is combining the technology with liquid...
Novavax’ VLP delivery tech could accelerate H1N1 vacc production
08-Sep-2009 - Novavax’ VLP delivery system has been the subject of industry excitement this week after the...
Controlled-release can deliver for generics firms, says Espicom
03-Sep-2009 - Wyeth’s battles to protect the controlled-release (CR) version of its anti-depressant Effexor are a sign...
News in brief
Novartis buys HySolv technology from BTG
02-Sep-2009 - Swiss drug major Novartis will UK specialty pharma firm BTG up to $10m (€7m) for...
Durect and King sign long-term Remoxy excipient supply deal
31-Aug-2009 - Chemicals firm Durect will supply drugmaker King Pharmaceuticals with two excipients used in the manufacture...
Silence collaborating on AtuRNAi drug delivery tech
27-Aug-2009 - Dainippon Sumitomo Pharma has entered into a collaboration to develop Silence Therapeutics’ AtuRNAi delivery technology...
Microneedle patch could boost compliance
24-Aug-2009 - Researchers have presented new microneedle drug delivery patches, which, using technology developed in the electronics...
Dry powder vaccine nears Phase I
18-Aug-2009 - A dry powder measles vaccine formulation and inhalers that could be as affordable as needle...
LSO trials light activated cancer treatment
13-Aug-2009 - Light Sciences Oncology (LSO) has begun treating the first patient in a Phase I trial...
Aptamers used for targeted cancer treatment
11-Aug-2009 - Researchers have developed a drug delivery vehicle using liposomes and aptamers that targets specific cancer...
Positive Phase II for intranasal antiemetic
04-Aug-2009 - Shin Nippon Biomedical Laboratories (SNBL) has posted a positive first report on the Phase II...
Medingo’s insulin patch approved; shares rocket
30-Jul-2009 - Medingo’s insulin dispensing patch has been approved by the US Food and Drug Administration (FDA),...
New liquid protein tech could improve drug delivery
28-Jul-2009 - Scientists at the University of Bristol in the UK and the Max Planck in Germany...
West buys Plastef’s delivery business
09-Jul-2009 - US contract manufacturer West Pharmaceutical Services has purchased French device firm Plastef Investissements’ drug...
3M rolls out plasma coating and face seal tech for pMDIs
10-Jun-2009 - 3M’s drug delivery unit believes its new plasma coating and face seal valve pMDI...
FDA revises ICH Q8 guidance
10-Jun-2009 - The FDA has revised its guidance on ICH Q8, adding an annex that clarifies the...
RXi presents RNA delivery data
08-Jun-2009 - At TIDES 2009 RXi Pharmaceuticals presented preclinical data on its RNA technologies, including research...


